Needham lowered the firm’s price target on Astera Labs (ALAB) to $100 from $140 and keeps a Buy rating on the shares. The company posted another beat and raise, driven by its Aries and Taurus product families, though the firm’s price target cut reflects multiple compression across the AI sector, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB:
- 3 Best Stocks to Buy Now, 5/7/2025, According to Top Analysts
- Astera Labs, Inc.: Strong Growth Potential Justifies Buy Rating Amid Product Expansion and Positive Outlook
- Astera Labs price target lowered to $100 from $130 at Roth Capital
- Astera Labs, Inc.: Strong Market Position and Growth Potential Justify Buy Rating
- Astera Labs price target raised to $75 from $70 at Barclays
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue